drugset / Trial / NCT04187014

Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss After Total Hip Replacement

NCT04187014

Phase 2 Completed 90 enrolled Carlos A Acosta-Olivo
RandomizedParallel-groupDouble-blindPrevention

Summary

This study compares two oral medications (tranexamic acid and aminocaproic acid) as hemostatic agent administered in patients undergoing primary total hip replacement

Timeline

Start
2020-02-06
Primary completion
2021-04-26
Completion
2021-04-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminocaproic Acid Small molecule 2000 mg Oral
Comparator Tranexamic Acid Small molecule 1300 mg Oral

Indications

No indication recorded.